Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression and genotype data from human fibroblasts and induced Pluripotent Stem cells from Parkinson's Disease patients

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE53426 | GEO | 2013/12/18

SECONDARY ACCESSION(S): PRJNA231955

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Gene expression and genotype data from human fibroblasts and induced Pluripotent Stem cells from Parkinson's Disease patients

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-12-18 | E-GEOD-53426 | biostudies-arrayexpress

Gene expression and SNP genotype data from induced Pluripotent Stem cells from Parkinson's Disease patients harbouring G2019S mutations in the LRRK2 gene

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2016-02-09 | E-GEOD-77664 | biostudies-arrayexpress

SNP data from human fibroblasts and induced Pluripotent Stem cells from Parkinson's Disease patients

2013-12-18 | GSE53425 | GEO

SNP data from human fibroblasts and induced Pluripotent Stem cells from Parkinson's Disease patients

Project description:We have generated human induced Pluripotent Stem cells (hiPSc) from Parkinson's Disease patients, using retrovirus-mediated delivery of reprogramming factors. hiPSc lines have been screened using SNP array to assess chromosomal stability (alongside the fibroblast lines from which they derived), and validation of the pluripotency of the hiPSc lines is provided by Pluritest assessment of transcriptome datasets, prior to differentiation to dopaminergic neuronal clutures and downstream functional assays. Fernandes H.J.R., Hartfield E.M., Badger J., Christian H. C., Emmanoulidou E., Vowles J., Evetts S., Vekrellis K., Talbot K., Hu M.T., James W., Cowley S.A., and Wade-Martins, R. Heterozygous glucocerebrosidase mutations in Parkinson's increase autophagic demand, but decrease capacity, in induced pluripotent stem cell-derived dopaminergic neuronal cultures. submitted for publication human iPSc lines were derived from human dermal fibroblasts from 2 Parkinson's Disease patients with heterozygous glucocerebrosidase mutations (GBA N370S) mutations, and 2 idiopathic Parkinson's Disease patients. SNP datasets from the 2 control individuals used in this study have been published previously [PMID 23951090; A mature physiological cellular model of human dopaminergic neurons Hartfield E.M., Yamasaki-Mann M., Fernandes H.J., Vowles., James W.S., Cowley S.A, and Wade-Martins R. In revision]

2013-12-18 | E-GEOD-53425 | biostudies-arrayexpress

Gene expression and SNP genotype data from induced Pluripotent Stem cells from Parkinson's Disease patients harbouring G2019S mutations in the LRRK2 gene

Project description:This SuperSeries is composed of the SubSeries listed below.

2016-02-09 | GSE77664 | GEO

Gene expression data from human fibroblasts and induced Pluripotent Stem cells from Parkinson's Disease patients

2013-12-18 | GSE53424 | GEO

Gene expression data from human fibroblasts and induced Pluripotent Stem cells from Parkinson's Disease patients

Project description:We have generated human induced Pluripotent Stem cells (hiPSc) from Parkinson's Disease patients, using retrovirus-mediated delivery of reprogramming factors. hiPSc lines have been screened using SNP array to assess chromosomal stability (alongside the fibroblast lines from which they derived), and validation of the pluripotency of the hiPSc lines is provided by Pluritest assessment of transcriptome datasets, prior to differentiation to dopaminergic neuronal clutures and downstream functional assays. human iPSc lines were derived from human dermal fibroblasts from 2 Parkinson's Disease patients with heterozygous glucocerebrosidase mutations (GBA N370S) mutations, and 2 idiopathic Parkinson's Disease patients. SNP datasets from the 2 control individuals used in this study have been published previously [PMID 23951090; A mature physiological cellular model of human dopaminergic neurons Hartfield E.M., Yamasaki-Mann M., Fernandes H.J., Vowles., James W.S., Cowley S.A, and Wade-Martins R. In revision]

2013-12-18 | E-GEOD-53424 | biostudies-arrayexpress

SNP Genotype and Gene Expression data from induced Pluripotent Stem cells from Parkinson's Disease patients harboring mutations in the GBA1 gene, and from healthy control donors

Project description:This SuperSeries is composed of the SubSeries listed below.

2017-06-01 | GSE99473 | GEO

Gene expression and genotype data from human fibroblasts and induced Pluripotent Stem cells from Parkinson's Disease patients

Project description:Gene expression and genotype data from human fibroblasts and induced Pluripotent Stem cells from Parkinson's Disease patients

| PRJNA231955 | ENA

Genotype and gene expression data from induced Pluripotent Stem cells from OPA1 Haploinsufficiency patients

Project description:This SuperSeries is composed of the SubSeries listed below.

2017-02-03 | GSE94433 | GEO